3,6-DMAD dihydrochloride is an acridine derivative that acts as a potent inhibitor of the IRE1α-XBP1s pathway; it promotes IL-6 secretion via the IRE1α-XBP1s pathway; it inhibits IRE1α oligomerization and ribonuclease (RNase) activity; it can be used in cancer research.